Göran Conradsson, CEO
Appointed: April 5, 2017.
Qualifications: MSc Chemical Engineering.
Experience: Since 2004 Göran has driven the business development of more than 15 cutting-edge Life Science technologies through his consultancy firm Venaticus AB. Prior to that he had senior sales, marketing and business development roles at, amongst others, Pharmacia (now GE), Biocore and BioInvent. Whilst at Pharmacia Göran was involved in large-scale chromatography for the production of protein-based therapies, and was based in Belgium and Germany for several years.
Current roles: Board Member of Venaticus AB, Board Member of Bulb Intelligence AB (with responsibility for marketing and sales), member of SwedenBIO’s Finance and Business Development Working Group.
Michael Owens, CFO
Appointed: May 15, 2018.
Experience: In a long corporate career Michael has been an Authorized Public Accountant for Ernst & Young AB, ‘Staff Accountant’ for Arthur Andersen & Co and CFO for, among others, AB Tre Cé System and Vitamex.
Current roles: CFO for Inhalation Sciences AB, Athera AB and Controller at Infant Bacterial Therapeutics AB, Sensidose AB and Asarina Pharma AB,
Previous roles: CEO of KCIF Fund Management AB, Controller at Karolinska Development AB, Board member of KD Incentive AB and Modus Therapeutics Holding AB (publ).